BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy

PURPOSE: BioPATH is a non-interventional study evaluating the relationship of molecular biomarkers (PTEN deletion/downregulation, PIK3CA mutation, truncated HER2 receptor [p95HER2], and tumor HER2 mRNA levels) to treatment responses in Asian patients with HER2+ advanced breast cancer treated with la...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung-Bae, Do, In-Gu, Tsang, Janice, Kim, Tae-You, Yap, Yoon-Sim, Cornelio, Gerardo, Gong, Gyungyub, Paik, Soonmyung, Lee, Suee, Ng, Ting-Ying, Park, Sarah, Oh, Ho-Suk, Chiu, Joanne, Sohn, Joohyuk, Lee, Moonhee, Choi, Young-Jin, Lee, Eun Mi, Park, Kyong-Hwa, Nathaniel, Christos, Ro, Jungsil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790855/
https://www.ncbi.nlm.nih.gov/pubmed/31163957
http://dx.doi.org/10.4143/crt.2018.598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790855/
https://www.ncbi.nlm.nih.gov/pubmed/31163957
http://dx.doi.org/10.4143/crt.2018.598

Ejemplares similares